metformin has been researched along with Dermatitis Medicamentosa in 7 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vildagliptin is a new drug used to treat diabetes mellitus (DM)." | 5.46 | A case of bullous pemphigoid ınduced by vildagliptin. ( Ersoy-Evans, S; Gököz, O; Gönül, M; Keseroglu, HO; Taş-Aygar, G, 2017) |
| "Vildagliptin is a new drug used to treat diabetes mellitus (DM)." | 1.46 | A case of bullous pemphigoid ınduced by vildagliptin. ( Ersoy-Evans, S; Gököz, O; Gönül, M; Keseroglu, HO; Taş-Aygar, G, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kridin, K | 1 |
| Bergman, R | 1 |
| Mumoli, L | 1 |
| Gambardella, A | 1 |
| Labate, A | 1 |
| Succurro, E | 1 |
| De Sarro, G | 1 |
| Arturi, F | 1 |
| Gallelli, L | 1 |
| Steber, CJ | 1 |
| Perkins, SL | 1 |
| Harris, KB | 1 |
| Keseroglu, HO | 1 |
| Taş-Aygar, G | 1 |
| Gönül, M | 1 |
| Gököz, O | 1 |
| Ersoy-Evans, S | 1 |
| Ramírez-Bellver, JL | 1 |
| Lopez, J | 1 |
| Macias, E | 1 |
| Fuertes, L | 1 |
| Andres, I | 1 |
| Alegria, V | 1 |
| Gimeno, I | 1 |
| Perez, A | 1 |
| Perez, Y | 1 |
| Requena, L | 1 |
| Monroe, JR | 1 |
| Koca, R | 1 |
| Altinyazar, HC | 1 |
| Yenidünya, S | 1 |
| Tekin, NS | 1 |
7 other studies available for metformin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes: Estimating the Risk of the New Agents and Characterizing the Patients.
Topics: Age Factors; Aged; Aged, 80 and over; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Pe | 2018 |
Rosacea-like facial rash related to metformin administration in a young woman.
Topics: Adult; Drug Eruptions; Exanthema; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin | 2014 |
Metformin-Induced Fixed-Drug Eruption Confirmed by Multiple Exposures.
Topics: Diabetes Mellitus, Type 2; Drug Eruptions; Female; Humans; Hypoglycemic Agents; Metformin; Middle Ag | 2016 |
A case of bullous pemphigoid ınduced by vildagliptin.
Topics: Adamantane; Administration, Cutaneous; Clobetasol; Complement C3; Diabetes Mellitus, Type 2; Dipepti | 2017 |
Metformin-Induced Generalized Fixed Drug Eruption With Cutaneous Hemophagocytosis.
Topics: Aged, 80 and over; Biopsy; Diabetes Mellitus, Type 2; Drug Eruptions; Drug Substitution; Histiocytes | 2017 |
What are these lesions that spread from the lips. Fixed drug eruption.
Topics: Adult; Aspirin; Biopsy, Needle; Drug Eruptions; Female; Humans; Hypoglycemic Agents; Metformin; Nonp | 2010 |
Psoriasiform drug eruption associated with metformin hydrochloride: a case report.
Topics: Adolescent; Biopsy; Drug Eruptions; Female; Humans; Hypoglycemic Agents; Metformin; Psoriasis | 2003 |